Objectives: The objective of this study was to determine
the ability of patients with advanced ovarian cancer to tolerate
intraperitoneal (IP) chemotherapy after having undergone optimal
cytoreductive surgery (OCRS) requiring splenectomy.
Conclusions: Patients who undergo splenectomy at the time of OCRS are just as able as those who do not have a splenectomy to complete a full course of IP chemotherapy. The median PFS is comparable in the two groups.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.